Weight Loss & Obesity News & Features
Pre-Ozempic Obesity Drugs: Effective and Budget-Friendly
- Weight Loss Drugs With Your Gym Membership? What to Know
April 24, 2024 — Weights, aerobics, and … Wegovy? Some in the fitness industry are moving to dispense the popular GLP-1 medications to club members, combining the new, easier method of losing weight with the old, more challenging one.
- The Fat You Can’t See Can Be Most Dangerous to Your Health
April 19, 2024 — A little visceral fat is helpful. It cushions your heart, lungs, and the organs in your gut. Too much, though, and it becomes a bad player. So what can you do to lessen your health risks?
- Gastric Sleeve Cheaper, More Effective Than Semaglutide
April 12, 2024 — Endoscopic sleeve gastroplasty (ESG), a nonsurgical weight loss procedure, is more cost-effective over a 5-year period than using semaglutide, the active ingredient in Ozempic, Wegovy, and other weight loss drugs, a new study shows.
- Speedy Eating and Late-Night Meals May Take Toll on Health
April 11, 2024 — A growing body of evidence shows that it's not just what and how much you eat that influence your health. How fast and when you eat also play a role.
- How WW, Noom Say They're Filling Obesity Medicine Gaps
March 29, 2024 — While applauding the role that these behavior-based weight management programs play in a comprehensive approach, an academic weight loss doctor thinks the order is backward.
- Doctors Wary of Young Adults Using Ozempic for Bikini Season
March 15, 2024 — With summer months approaching – and pressures that come with showing more skin – more and more young adults are looking to GLP-1 medications, like Ozempic, to get prepped for “swimsuit season.” But experts say there are critical things to consider before reaching for such medications, particularly for those struggling with body image issues.
- Beyond the Shots: Focusing on Gut Health Can Aid Weight Loss
February 22, 2024 — It might not produce results as dramatic as regular injections, but you can get everything you need in a grocery store, for far less money -- and this approach has the potential to improve your health in numerous ways.
- Weight Loss Health Benefits Start Sooner Than You May Think
If you’re looking to lose weight for health benefits, you may not need as much weight loss as you think. Read about the benefits of modest weight loss.
- Study Suggests Mind-Body Benefits of Weight Loss Drugs
February 8, 2024 — People taking a popular type of drug for weight loss or to manage diabetes have a decreased likelihood of being newly diagnosed with depression or anxiety, according to an analysis of millions of people’s health records.
- Weight Loss Drugs Should Be Taken With Diet and Exercise
February 8, 2024 — People who take weight loss drugs should not neglect diet and exercise. Here's what to know.
- Weight Loss Drug Zepbound May Significantly Reduce Blood Pressure
February 5, 2024 — People with obesity who took the weight loss drug Zepbound experienced a reduction in blood pressure similar to or better than results usually seen with traditional hypertension drugs, a new analysis shows.
- Big Move: Eli Lilly Offers Obesity Drug Directly to Consumers
January 25, 2024 — For many of the 42 million Americans with obesity, weight loss medications such as Wegovy, Saxenda, and the brand-new Zepbound can be a godsend, helping them lose the excess pounds they’ve struggled with for decades or a lifetime.
- Many Patients Who Stop Weight Loss Drug Keep Pounds Off: Study
January 24, 2024 — An analysis of health records for people who lost weight while being prescribed drugs like Wegovy, Saxenda, or Ozempic showed that many maintained most of their weight loss or continued to shed pounds within the year after their prescription ended.
- Study Shows Loneliness Raises Mortality Rate for Obese People
January 23, 2024 — Loneliness has been known to be a serious health problem, and a new report makes the case that the suffering is worse for people who are obese.
- No Link Between Obesity, Diabetes Drugs and Suicidal Thoughts
January 11, 2024 — The FDA said Thursday that a review of a class of popular diabetes and obesity drugs found no connection between the medications and a rise in suicidal thoughts. The drugs include Ozempic, Wegovy, and Mounjaro.
- Wegovy, Ozempic Not Linked to Suicide Ideation, Study Finds
January 5, 2024 — People taking semaglutide – the active ingredient in the weight loss drug Wegovy and the type 2 diabetes drug Ozempic – did not have an increase in suicidal thoughts, compared to people taking other drugs for those conditions, according to a study published in Nature Medicine.
- FDA Looking Into Three Side Effects Reported With Weight Loss Drugs
January 4, 2024 — The FDA is formally looking into reports that some people who took popular diabetes and weight loss drugs had suicidal thoughts or two other health problems.
- FDA Seizes ‘Thousands of Units’ of Fake Ozempic
December 22, 2023 — The FDA says it has seized “thousands of units” of counterfeit Ozempic that are circulating while demand for the weight loss drug exceeds supply.
- What Causes Obesity? More Science Points to the Brain
December 15, 2023 — A new way of looking at a misunderstood disease is revolutionizing treatments and transforming lives.
- Users of Weight Loss Drugs Regain Weight after Stopping Use
December 14, 2023 — New drugs being used for weight loss might bring results that are as temporary as they are dramatic, according to a study published this week in the Journal of the American Medical Association.
- Ozempic May Become Even Harder to Find
November 15, 2023 — German regulator BfArM is considering a halt on the export of Ozempic because high demand is creating a scarcity of the drug, Reuters reports.
- Hospitalizations Linked to Fake Ozempic Prompt FDA Investigation
November 8, 2023 — Suspected counterfeits of a popular weight loss drug are linked to the hospitalization of at least three people, federal data shows.
- FDA Approves Another New Drug for Obesity
November 8, 2023 — The FDA on Wednesday approved an injection drug Zepbound for chronic weight management for adults with obesity or those who are overweight and have at least one weight-related condition, such as high blood pressure or high cholesterol.
- Researchers Suggest Fructose Is Central Factor Causing Obesity
October 20, 2023 — Research published this week shows that fructose may be the central factor driving obesity because it triggers cravings for fatty foods and carbohydrates, while blocking the body’s ability to use stored energy from fat.
- Taking a New Obesity Drug and Birth Control Pills? Be Careful
October 18, 2023 — Many women on oral contraceptives are unaware that drugs like Mounjaro may result in the unexpected: pregnancy.
- Scientists Find the ‘On’ Switch for Energy-Burning Brown Fat
October 17, 2023 — The discovery from UCLA could open the door to new treatments for obesity and type 2 diabetes.
- Average Weight Loss of 60 Pounds Reported in Mounjaro Trial
October 16, 2023 — People at high risk of getting type 2 diabetes lost on average more than 18% of their weight when taking the weight loss drug tirzepatide, according to clinical trial results published over the weekend.
- Distribution Network Tries to Help Crack Down on Fake Ozempic
October 6, 2023 — Counterfeit versions of the weight loss drug Ozempic are showing up in a variety of schemes, and sometimes the fraudulent offers are extremely realistic, a health care trade group warned its members this week.
- Popular Weight Loss Drugs Raise Risk of More Stomach Trouble
October 5, 2023 — People taking popular medications like Ozempic, Wegovy, and Rybelsus for weight loss are at higher risk of potentially serious stomach and intestinal issues, compared to people taking a weight loss drug approved in 2014, a large study reveals.
- FDA Adds Warning of Intestinal Blockages to Ozempic Label
September 28, 2023 — The FDA has received more than 8,500 reports of gastrointestinal issues among people taking medications like Ozempic and Wegovy, the latter of which is approved for weight loss.
- What Is Food Noise and How Can You Quiet It?
Food “noise” is what some people call their internal chatter about food. For some people, it gets out of hand.
- More States Added to List With High Obesity Prevalence
September 22, 2023 — In 22 states across the nation, more than 1 in 3 adults have obesity, according to new data released Thursday by the CDC. That’s up from 19 states in 2021, and none a decade ago.
- Is Obesity Different in Asian Americans? Expert Q&A
Asian Americans have a lower obesity rate than other ethnic groups, but there are key differences to be aware of. Here’s what you need to know.
- Obesity: A Holistic Approach
In this webinar, Octavia Pickett-Blakely, MD, MHS, explained what a holistic approach to weight management is.
- Who Gets Wegovy? (Hint: Not Always Those Who Need it Most)
Wegovy and other semaglutide-containing drugs can help people with obesity lose weight. But not everyone who needs these effective weight loss drugs can get them.
- Ozempic and Wegovy Fakes Wreak Havoc: How to Stay Safe
August 22, 2023 — Patients are willing to bet their health on Wegovy and Ozempic fakes while drugmaker Novo Nordisk struggles to meet demand.
- Curiosity About Weight Loss Drugs Opens Treatment Doors
August 15, 2023 — The results of a new poll could be a sign that the conditions of obesity and being overweight are increasingly being viewed as diseases. Reducing stigma is a critical step in creating a pathway for people to seek treatment.
- Supply of Weight Loss Drug Wegovy Will Continue to be Limited
August 10, 2023 — Novo Nordisk, manufacturer of the weight loss drug Wegovy, said Thursday that it will continue to restrict supplies of starter doses of the drug in the United States. This restriction will likely continue into next year.
- Why Is It So Hard to Lose Weight and Keep It Off? Q&A With Amanda Velazquez, MD
In this WebMD webinar, viewers asked Amanda Velazquez, MD, about what things affect your weight and why weight loss can be challenging.
- Weight Loss Drug Wegovy May Help Prevent Heart Attacks
August 8, 2023 — Study results show semaglutide for weight loss (Wegovy) cut problems in the heart and blood vessels in a 17,000-person trial, which should reframe the health benefit of this weight loss drug.
- How Newly Discovered Genes Might Fit Into Obesity
August 8, 2023 — Identifying specific genes adds to growing evidence that biology, in part, drives obesity. Researchers hope the findings will lead to effective treatments.
- Lawsuit Alleges Untold Stomach Risks From Ozempic, Mounjaro
August 3, 2023 — A new lawsuit from a woman with type 2 diabetes alleges that the makers of the drugs Ozempic and Mounjaro did not provide adequate warnings for the severity of gastrointestinal problems caused by the popular medicines.
- Using Ozempic for 'Minor' Weight Loss: Fair or Foul?
August 1, 2023 — Ozempic is already sometimes difficult to find. Now those who are using to drop a few pounds are making it harder for those who need it.
- Why Is It So Hard to Lose Weight and Keep It Off?
In this webinar, Amanda Velazquez, MD, explained why obesity is a chronic disease and what goes into losing weight without gaining it back.
- Study: Watching TV as a Child Linked to Adult Health Problems
July 24, 2023 — People who watched a lot of television as a child often have health problems in adulthood, such as high blood pressure and obesity, says a study conducted over 50 years and published in the online journal Pediatrics.
- Did Bariatric Surgery Lead to Lisa Marie Presley’s Death?
July 17, 2023 — A medical examiner’s report points to small bowel obstruction as the cause of death, but was it caused by bariatric surgery years earlier?
- Most People Stop Taking Costly Weight Loss Drugs, Review Shows
July 12, 2023 — Most people using new, highly touted prescription drugs to lose weight, such as Wegovy, stop taking them after a year, a new report says. People who used the drugs had “a substantial increase in health care” costs over the year, says an analysis by Prime Therapeutics.
- EU Panel Probes Cases of Suicidal Thoughts on Weight Loss Drugs
July 11, 2023 — The European Medicines Agency is investigating Ozempic and another drug that leads to weight loss amid fears that the medicines may increase the risk of suicide.
- Is BMI Flawed as a Measure of Overall Health?
July 6, 2023 — New research takes aim at the long-standing measurement of health.